SPOTLIGHT -
Point: Should Active Surveillance Be Used for Gleason 3+4 Prostate Cancer?
In this Point/Counterpoint, Drs. Bhat and Punnen argue that active surveillance can be beneficial for patients with intermediate-risk prostate cancer.
